
|
- Click on the title
of each paper to access MedLine abstract at NLM site Aoki T, Umekita N, Tanaka S, Noda K, Warabi M, Kitamura M. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery. 2008 Jun;143(6):706-14. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008 Jul;15(7):1908-17.Tanaka K, Shimada H, Matsumoto C, Matsuo K, Takeda K, Nagano Y, Togo S. Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer. World J Surg. 2008 May 3. Fidarova EF, El-Emir E, Boxer GM, Qureshi U, Dearling JL, Robson MP, Begent RH, Trott KR, Pedley RB. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy. Clin Cancer Res. 2008 May 1;14(9):2639-46.Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006039. Review. Guzzetti E, Pulitanň C, Catena M, Arru M, Ratti F, Finazzi R, Aldrighetti L, Ferla G. Impact of type of liver resection on the outcome of colorectal liver metastases: a case-matched analysis. J Surg Oncol. 2008 May 1;97(6):503-7.Fuks D, Cook MC, Bréhant O, Henegar A, Dumont F, Chatelain D, Yzet T, Mulieri G, Joly JP, Nguyen-Khac E, Dupas JL, Mauvais F, Verhaeghe P, Regimbeau JM. Colorectal carcinoma with potentially resectable metastases: Factors associated with the failure of curative schedule. Gastroenterol Clin Biol. 2008 Apr;32(4):390-400. Eisenberger A, Whelan RL, Neugut AI. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis. 2008 Jun;23(6):559-68.Funaioli C, Longobardi C, Martoni AA. The impact of chemotherapy on overall survival and quality of life of patients with metastatic colorectal cancer: a review of phase III trials. J Chemother. 2008 Feb;20(1):14-27. Lordan JT, Karanjia ND, Quiney N, Fawcett WJ, Worthington TR. A 10-year study of outcome following hepatic resection for colorectal liver metastases - the effect of evaluation in a multidisciplinary team setting. Eur J Surg Oncol. 2008 Mar 5 Tabernero J, Pfeiffer P, Cervantes A. Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration? Oncologist. 2008 Feb;13(2):113-9.Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery. 2008 Mar;143(3):384-93. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery. 2008 Feb;143(2):259-70.Robertson JH, Iga AM, Sales KM, Winslet MC, Seifalian AM. Integrins: a method of early intervention in the treatment of colorectal liver metastases. Curr Pharm Des. 2008;14(3):296-305. Review. Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D'Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg. 2008 Jan;247(1):109-17.Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, Pulitanň C, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008 Jan;32(1):93-103. Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. Eur J Surg Oncol. 2008 Feb;34(2):180-4.Rotolo N, De Monte L, Imperatori A, Dominioni L. Pulmonary resections of single metastases from colorectal cancer. Surg Oncol. 2007 Dec;16 Suppl 1:S141-4. Epub 2007 Nov 26. Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, Pulitanň C, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008 Jan;32(1):93-103. Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg. 2007 Nov;142(11):1087-92.Treska V, Skalicky T, Liska V, Ferda J. Repeated procedures for colorectal liver metastases. Hepatogastroenterology. 2007 Sep;54(78):1775-8. Brent A, Talbot R, Coyne J, Nash G. Should indeterminate lung lesions reported on staging CT scans influence the management of patients with colorectal cancer?Colorectal Dis. 2007 Nov;9(9):816-8.Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007 Oct 10;25(29):4575-80. Furák J, Troján I, Szöke T, Wolfárd A, Nagy E, Németh I, Tiszlavicz L, Lázár G. Lung cancer as a second primary malignant tumor: prognostic values after surgical resection. Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):50-3. Epub 2007 Oct 9.Malik HZ, Farid S, Al-Mukthar A, Anthoney A, Toogood GJ, Lodge JP, Prasad KR. A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Ann Surg Oncol. 2007 Dec;14(12):3519-26. Epub 2007 Oct 3. Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?Ann Surg Oncol. 2008 Jan;15(1):144-57. Epub 2007 Sep 29.Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007 Oct;246(4):559-65; discussion 565-7. Tang PA, Bentzen SM, Chen EX, Siu LL. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy. J Clin Oncol. 2007 Oct 10;25(29):4562-8. Epub 2007 Sep 17. Review.Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg. 2007 Nov;11(11):1498-504; discussion 1504-5. Epub 2007 Sep 11. Suppiah A, White TJ, Roy-Choudhury SH, Breen DJ, Cast J, Maraveyas A, Hartley JE, Monson JR. Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg. 2007;24(5):358-60. Epub 2007 Sep 4.Nordlinger B, Van Cutsem E, Rougier P, Köhne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, Giuliante F, Glimelius B, Golling M, Gruenberger T, Tabernero J, Wasan H, Poston G; European Colorectal Metastases Treatment Group. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 2007 Sep;43(14):2037-45. Epub 2007 Sep 4. Review.
Zhang HZ, Dong SX, Zhou ZX,
Shao YF. [Outcome of
surgical therapy for liver metastasis of colorectal cancer: analysis of 75
cases] Zhonghua Yi Xue Za
Zhi. 2007 Jun 5;87(21):1457-61. Chinese. Liska V, Holubec L Jr, Treska V, Skalicky T, Sutnar A, Kormunda S, Pesta M, Finek J, Rousarova M, Topolcan O. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases. Anticancer Res. 2007 Jul-Aug;27(4C):2861-4.
Kemeny N.
Presurgical chemotherapy in patients being considered for liver resection.
Oncologist. 2007 Jul;12(7):825-39. Yan TD, Chu F, Black D, King DW, Morris DL. Synchronous Resection of Colorectal Primary Cancer and Liver Metastases. World J Surg. 2007 May 30;
Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol. 2007 Mar 8; Jovine E, Biolchini F, Talarico F, Lerro FM, Mastrangelo L, Selleri S, Landolfo G, Martuzzi F, Iusco DR, Lazzari A. Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis. 2007 Mar;9(3):245-52. Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Rague J, Serrano T, Fabregat J. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum. 2007 Apr;50(4):478-88. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol. 2007 Apr;14(4):1336-46. Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, Oyen WJ, Krabbe PF, Punt CJ. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol. 2007 Mar;14(3):1161-9 Thelen A, Jonas S, Benckert C, Schumacher G, Lopez-Hanninen E, Rudolph B, Neumann U, Neuhaus P. Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol. 2007 Apr;33(3):324-8. Lopez Andujar R, Montalva Oron E, Moya Herraiz A, Redondo Cano C, San Juan Rodriguez F, Pareja Ibars E, De Juan Burgueno M, Orbis Castellanos F, Mir Pallardo J. Reflections on 250 interventions for colorectal carcinoma metastases to the liver.] Cir Esp. 2007 May;81(5):269-75. Spanish. Khan AZ, Karanjia ND. The impact of staging laparoscopy prior to hepatic resection for colorectal metastases. Eur J Surg Oncol. 2007 Jan 29; Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg. 2007 Jan;11(1):66-72. Thelen A, Jonas S, Benckert C, Spinelli A, Lopez-Hanninen E, Rudolph B, Neumann U, Neuhaus P. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis. 2007 Feb 21;
Bipat S, van Leeuwen MS, Ijzermans JN,
Comans EF, Planting AS, Bossuyt PM, Greve JW, Stoker J.
Evidence-base guideline on management of colorectal liver metastases in the
Netherlands. Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Rague J, Serrano T, Fabregat J. Surgical Resection of Colorectal Liver Metastases in Patients with Expanded Indications: A Single-Center Experience with 501 Patients. Dis Colon Rectum. 2007 Feb 7; Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007 Feb 15;109(4):718-26. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol. 2007 Apr;14(4):1336-46. Baize N, Gerard B, Bleiberg H, Caroli-Bosc F, Berthier F, Legendre H, Pector JC, Hendlisz A. Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases. Gastroenterol Clin Biol. 2006 Dec;30(12):1349-53. Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, Oyen WJ, Krabbe PF, Punt CJ. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol. 2007 Mar;14(3):1161-9.
Antoniou A, Lovegrove RE, Tilney HS,
Heriot AG, John TG, Rees M, Tekkis PP, Welsh FK.
Meta-analysis of clinical outcome after first and second liver resection for
colorectal metastases. Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg. 2007 Feb;31(2):167-72. Muratore A, Zorzi D, Bouzari H, Amisano M, Massucco P, Sperti E, Capussotti L. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol. 2007 Feb;14(2):766-70.
Capussotti L, Vigano' L, Ferrero A, Lo Tesoriere R,
Ribero D, Polastri R.
Timing of resection of liver metastases synchronous to colorectal tumor:
proposal of prognosis-based decisional model.
Antoniou A, Lovegrove
RE, Tilney HS, Heriot AG, John TG, Rees M, Tekkis PP, Welsh FK.
Meta-analysis of clinical outcome after first and second liver
resection for colorectal metastases. Lee WS, Yun SH, Chun HK, Lee WY, Yun HR, Kim J, Kim K, Shim YM. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis. 2006 Nov 16; Kanjo T, Albertini M, Weber S. Long-term disease-free survival after adrenalectomy for isolated colorectal metastases. Asian J Surg. 2006 Oct;29(4):291-3.
Sperti E, Faggiuolo R, Gerbino A, Magnino A,
Muratore A, Ortega C, Ferraris R, Leone F, Capussotti L, Aglietta
M.
Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229
patients. The impact of a multidisciplinary approach.
Yedibela S, Klein P, Feuchter K,
Hoffmann M, Meyer T, Papadopoulos T, Gohl J, Hohenberger W.
Surgical management of pulmonary metastases from colorectal cancer in 153
patients. de Geus-Oei LF, Wiering B, Krabbe PF, Ruers TJ, Punt CJ, Oyen WJ. FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma. Ann Oncol. 2006 Nov;17(11):1650-5. Machi J, Oishi AJ, Sumida K, Sakamoto K, Furumoto NL, Oishi RH, Kylstra JW. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J. 2006 Jul-Aug;12(4):318-26. Osborne D, Pappas E, Alexander G, Boe B, Cantor AB, Rosemurgy A, Zervos E. A complication-free course ensures a survival advantage in patients after regional therapy for metastatic colorectal cancer. Am Surg. 2006 Jun;72(6):505-10. Iizasa T, Suzuki M, Yoshida S, Motohashi S, Yasufuku K, Iyoda A, Shibuya K, Hiroshima K, Nakatani Y, Fujisawa T. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg. 2006 Jul;82(1):254-60. Oussoultzoglou E, Bachellier P, Rosso E, Scurtu R, Lucescu I, Greget M, Jaeck D. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg. 2006 Jul;244(1):71-9. Titu LV, Breen DJ, Nicholson AA, Hartley J, Monson JR. Is routine magnetic resonance imaging justified for the early detection of resectable liver metastases from colorectal cancer? Dis Colon Rectum. 2006 Jun;49(6):810-5. Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg. 2006 Aug;93(8):1001-6 Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ. Quality of life after surgical treatment of colorectal liver metastases. Br J Surg. 2006 Aug;93(8):1007-14. Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P.Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol. 2006 Aug;32(6):632-6. Avital I, DeMatteo R. Combined resection of liver and lung metastases for colorectal cancer. Thorac Surg Clin. 2006 May;16(2):145-55, vi.
Elias D, Benizri E,
Pocard M, Ducreux M, Boige V, Lasser P.
Treatment of synchronous peritoneal carcinomatosis and liver
metastases from colorectal cancer. Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg. 2006 Apr;93(4):457-64. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006 May;13(5):668-76. Homsi J, Garrett CR. Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer. Cancer Control. 2006 Jan-Feb;13(1):42-7.
Kemeny NE, Niedzwiecki D, Hollis DR,
Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE 2nd, Zhang
C, Mayer RJ.
Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From
Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and
Molecular Markers (CALGB 9481). Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol. 2006 Mar;13(3):353-62.
Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F,
Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O, Filipponi F, Falcone A.
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables
surgical resection of metastases in patients with initially unresectable
metastatic colorectal cancer. Shimada H, Tanaka K, Matsuo K, Togo S. Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg. 2005 Dec 1;:1-13 Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol. 2005 Nov 20;23(33):8490-9. Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A, Olivari N, Makuuchi M. "Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg. 2005 Oct;201(4):517-28. Nagano Y, Nojiri K, Matsuo K, Tanaka K, Togo S, Ike H, Shimada H. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg. 2005 Oct;201(4):511-6. McIntosh J, Sylvester PA, Virjee J, Callaway M, Thomas MG. Pulmonary staging in colorectal cancer - is computerised tomography the answer? Ann R Coll Surg Engl. 2005 Sep;87(5):331-3. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005 Sep;92(9):1155-60.
Jones OM, Rees M, John TG, Bygrave S, Plant G.
Biopsy of resectable colorectal liver metastases causes tumour dissemination and
adversely affects survival after liver resection. Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, Tsuta K, Kim YH, Nishiwaki Y, Kodama T, Iwasaki M, Ochiai A. Predictive factors for local recurrence of resected colorectal lung metastases. Ann Thorac Surg. 2005 Sep;80(3):1040-5.
Zubeldia JM,
Bednarczyk EM, Baker JG, Nabi HA.
The economic impact of 18FDG positron emission tomography in the
surgical management of colorectal cancer with hepatic
metastases. Wang P, Chen Z, Huang WX, Liu LM. Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials. World J Gastroenterol. 2005 Jul 7;11(25):3817-22. Allen PJ, Nissan A, Picon AI, Kemeny N, Dudrick P, Ben-Porat L, Espat J, Stojadinovic A, Cohen AM, Fong Y, Paty PB. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005 Jul;201(1):57-65. Cartwright T, Lopez T, Vukelja SJ, Encarnacion C, Boehm KA, Asmar L. Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2005 May;5(1 Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist. 2005 Apr;10(4):250-61.
Elias D, Baton O, Sideris L, Boige V, Malka
D, Liberale G, Pocard M, Lasser P.
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy
to treat technically unresectable multiple colorectal liver metastases. Child PW, Yan TD, Perera DS, Morris DL. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Dis Colon Rectum. 2005 Apr;48(4):744-8. Ogata Y, Matono K, Hayashi A, Takamor S, Miwa K, Sasatomi T, Ishibashi N, Shida S, Shirouzu K. Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those afte first pulmonary resection in colorectal cancer. World J Surg. 2005 Mar;29(3):363-8. Chafai N, Chan CL, Bokey EL, Dent OF, Sinclair G, Chapuis PH. What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? Colorectal Dis. 2005 Mar;7(2):176-81. Ogata Y, Matono K, Hayashi A, Takamor S, Miwa K, Sasatomi T, Ishibashi N, Shida S, Shirouzu K. Repeat Pulmonary Resection for Isolated Recurrent Lung Metastases Yields Results Comparable to Those after First Pulmonary Resection in Colorectal Cancer. World J Surg. 2005 Feb 10 Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Ishizu K, Yasuda S, Makuuchi H, Murayama C. Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis. Jpn J Clin Oncol. 2005 Jan;35(1):18-22. Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, Herfarth C, von Knebel Doeberitz M, Weitz J. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg. 2005 Feb;241(2):199-205 Yamamoto H, Nagino M, Kamiya J, Hayakawa N, Nimura Y. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe. Surgery. 2005 Jan;137(1):26-32. Christophi C, Nikfarjam M, Malcontenti-Wilson C, Muralidharan V. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.World J Surg. 2004 Oct;28(10):987-94. Zalcberg JR, Kemeny NE. Systemic or regional chemotherapy for liver metastases from colorectal cancer: has the wheel stopped spinning? Cancer J. 2004 Sep-Oct;10(5):271-9. Conzelmann M, Linnemann U, Berger MR. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis. 2004 Sep 30; Aschele C, Debernardis D, Lonardi S, Bandelloni R, Casazza S, Monfardini S, Gallo L. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy. J Clin Oncol. 2004 Sep 15;22(18):3758-65. Kopp I, Bauhofer A, Koller M. Understanding quality of life in patients with colorectal cancer: comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population. Inflamm Res. 2004 Aug;53 Suppl 2:S130-5. Epub 2004 Aug 10. Teague BD, Morrison CP, Court FG, Chin VT, Costello SP, Kirkwood ID, Maddern GJ. Role of FDG-PET in surgical management of patients with colorectal liver metastases. ANZ J Surg. 2004 Aug;74(8):646-52. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004 Aug 17;141(4):264-71 Fietkau R, Zettl H, Klocking S, Kundt G. Incidence, Therapy and Prognosis of Colorectal Cancer in Different Age GroupsA Population-Based Cohort Study of the Rostock Cancer Registry. Strahlenther Onkol. 2004 Aug;180(8):478-87. Lin J, Zhang SM, Cook NR, Rexrode KM, Lee IM, Buring JE. Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control. 2004 Aug;15(6):581-9.
Vogt C, Cohnen M, Beck A, vom Dahl S, Aurich V, Modder U,
Haussinger D.
Detection of colorectal polyps by multislice CT colonography with ultra-low-dose
technique: comparison with high-resolution videocolonoscopy.
Van Breda SG, Van Agen E, Engels LG, Moonen EJ, Kleinjans
JC, Van Delft JH.
Altered
vegetable intake affects pivotal carcinogenesis pathways in colon mucosa from
adenoma patients and controls. Carcinogenesis. 2004 Jul 22 UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ. 2004 Jul 17;329(7458):133 Davies RJ, Collins CD, Vickery CJ, Eyre-Brook I, Welbourn R. Reduction in the proportion of patients with colorectal cancer presenting as an emergency following the introduction of fast-track flexible sigmoidoscopy: a three-year prospective observational study. Colorectal Dis. 2004 Jul;6(4):265-7. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004 Jun;126(7):1674-80. Brown G, Davies S, Williams GT, Bourne MW, Newcombe RG, Radcliffe AG, Blethyn J, Dallimore NS, Rees BI, Phillips CJ, Maughan TS. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer. 2004 Jul 5;91(1):23-9. Loeve F, van Ballegooijen M, Boer R, Kuipers EJ, Habbema JD. Colorectal cancer risk in adenoma patients: a nation-wide study. Int J Cancer. 2004 Aug 10;111(1):147-51
Rabeneck L, Paszat LF. A population-based estimate of the extent of
colorectal cancer screening in Ontario. Bandipalliam P, Balmana J, Syngal S. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery. 2004 Jun;135(6):683-9. Rosa F, Meimarakis G, Stahl A, Bumm R, Hahn K, Tatsch K, Dresel S. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin. 2004 Aug;43(4):135-40. Teague BD, Morrison CP, Court FG, Chin VT, Costello SP, Kirkwood ID, Maddern GJ. Role of FDG-PET in surgical management of patients with colorectal liver metastases. ANZ J Surg. 2004 Aug;74(8):646-52. Vogelsang H, Haas S, Hierholzer C, Berger U, Siewert JR, Prauer H. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004 Aug;91(8):1066-71. Negri F, Musolino A, Cunningham D, Pastorino U, Ladas G, Norman AR. Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy. Clin Colorectal Cancer. 2004 Jul;4(2):101-6.
Yasui
K, Shimizu Y, Hirai T, Kanemitsu Y, Kato T.
Surgical
treatment for colorectal liver metastases--results of multi-institute study for
effects of radical hepatectomy
Gan
To Kagaku Ryoho. 2004 May;31(5):690-4.
Julianov
A, Karashmalakov A, Rachkov I, Hristov H.
Treatment of colorectal cancer with synchronous bilobar liver metastases with
simultaneous bowel and liver resection plus radiofrequency ablation.
Dawson
LA, Lawrence TS.
The role of radiotherapy in the treatment of liver metastases.
Cancer
J. 2004 Mar-Apr;10(2):139-44.
Elaraj
DM, Alexander HR.
Current
role of hepatic artery infusion and isolated liver perfusion for the treatment
of colorectal cancer liver metastases. Cancer
J. 2004 Mar-Apr;10(2):128-38.
Nelson
RL, Freels S.
A systematic review of hepatic artery chemotherapy after hepatic resection of
colorectal cancer metastatic to the liver.
Dis
Colon Rectum. 2004 May;47(5):739-45. Epub 2004 Mar 25.
Tanaka
K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I, Sekido H, Togo S, Ike H.
Metastatic
tumor doubling time: most important prehepatectomy predictor of survival and
nonrecurrence of hepatic colorectal cancer metastasis.
World
J Surg. 2004 Mar;28(3):263-70.
Tanaka K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I, Sekido H, Togo S, Ike H. Metastatic Tumor Doubling Time: Most Important Prehepatectomy Predictor of Survival and Nonrecurrence of Hepatic Colorectal Cancer Metastasis. World J Surg. 2004 Feb King J, Glenn D, Clark W, Zhao J, Steinke K, Clingan P, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg. 2004 Feb;91(2):217-23. Reddy RH, Kumar B, Shah R, Mirsadraee S, Papagiannopoulos K, Lodge P, Thorpe JA. Staged pulmonary and hepatic metastasectomy in colorectal cancer--is it worth it? Eur J Cardiothorac Surg. 2004 Feb;25(2):151-4 Kanemitsu Y, Kato T, Hirai T, Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004 Jan;91(1):112-20. Shimada H, Tanaka K, Masui H, Nagano Y, Matsuo K, Kijima M, Ichikawa Y, Ike H, Ooki S, Togo S. Results of surgical treatment for multiple (>/=5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg. 2004 Jan 9 Patel NA, Keenan RJ, Medich DS, Woo Y, Celebrezze J, Santucci T, Maley R, Landreneau RL, Roh MS. The presence of colorectal hepatic metastases does not preclude pulmonary metastasectomy. Am Surg. 2003 Dec;69(12):1047-53; discussion 1053. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results. Radiology. 2003 Dec;229(3):821-9. Fukunaga K, Takada Y, Otsuka M, Todoroki T, Fukao K. Resection of localized recurrences after hepatectomy of colorectal cancer metastases. Hepatogastroenterology. 2003 Nov-Dec;50(54):1894-7. Linnemann U, Schimanski CC, Gebhardt C, Berger MR. Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Int J Colorectal Dis. 2003 Nov 21 [Epub ahead of print] Watanabe I, Arai T, Ono M, Sugito M, Kawashima K, Ito M, Nagai K, Saito N. Prognostic factors in resection of pulmonary metastasis from colorectal cancer. Br J Surg. 2003 Nov;90(11):1436-40. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg. 2003 Sep;126(3):732-9. Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, Nofroni I. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg. 2003 Sep;197(3):386-91. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003 Sep;90(9):1131-6.Higashiyama M, Kodama K, Higaki N, Takami K, Murata K, Kameyama M, Yokouchi H. Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis. Jpn J Thorac Cardiovasc Surg. 2003 Jul;51(7):289-96. Metcalfe MS, Close JS, Iswariah H, Morrison C, Wemyss-Holden SA, Maddern GJ. The value of laparoscopic staging for patients with colorectal metastases. Arch Surg. 2003 Jul;138(7):770-2. Naredi P, Oman M, Blind PJ, Lindner P, Gustavsson B, Hafstrom L. A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver metastases. Eur J Surg Oncol. 2003 Jun;29(5):459-66.Ishikawa K, Hashiguchi Y, Mochizuki H, Ozeki Y, Ueno H. Extranodal cancer deposit at the primary tumor site and the number of pulmonary lesions are useful prognostic factors after surgery for colorectal lung metastases. Dis Colon Rectum. 2003 May;46(5):629-36. Taschieri AM, Elli M, Vignati GA, Montecamozzo G, Danelli PG, Kurihara H, Poliziani D. Repeated liver resection for recurrent metastases from colorectal cancer. Hepatogastroenterology. 2003 Mar-Apr;50(50):472-4. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for
colorectal liver metastases. Br J Surg. 2003 May;90(5):567-74. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002 Jul;137(7):833-40.Kemeny M. Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colorectal cancer. Cancer J. 2002 May-Jun;8 Suppl 1:S82-8. Yamaguchi J, Komuta K, Matsuzaki S, Okudaira S, Fujioka H, Kanematsu T. Mode of Infiltrative Growth of Colorectal Liver Metastases Is a Useful Predictor of Recurrence after Hepatic Resection. World J Surg. 2002 May 29 [epub ahead of print] Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002 Jun;235(6):863-71. Review. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002 Jun;235(6):759-66. Ike H, Shimada H, Ohki S, Togo S, Yamaguchi S, Ichikawa Y. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum. 2002 Apr;45(4):468-73; discussion 473-5. Clavien PA, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery. 2002 Apr;131(4):433-42. Rizk
NP, Downey RJ. Resection of pulmonary metastases from colorectal
cancer. Semin Thorac Cardiovasc Surg. 2002 Jan;14(1):29-34. |